Search for Clinical Trial Results
Leukemia-Lymphoma, Adult T-Cell - 25 Studies Found
Status | Study |
Completed |
Study Name: Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia Condition: Leukemia, Adult T-Cell Date: 2005-07-07 Interventions: Biological: Denileukin diftitox (Ontak) Patients will be treated with Denileukin Diftitox 9 mcg/kg/d int |
Completed |
Study Name: Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1 Condition: Human T-Lymphoma Virus Type I Date: 2006-06-19 |
Recruiting |
Study Name: High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant Condition:
Date: 2013-09-03 |
Completed |
Study Name: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma Condition: Acute T-Cell Leukemia-Lymphoma Date: 2003-05-20 Interventions: Biological: Alemtuzumab Infusion of Campath-1H 3 mg on day # 1, 10 mg on day #2, and 30 mg day # 3 follo |
Terminated |
Study Name: Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma Condition:
Date: 2009-02-28 Interventions:
|